Literature DB >> 32370979

ACR Appropriateness Criteria® Chronic Liver Disease.

Mustafa R Bashir1, Jeanne M Horowitz2, Ihab R Kamel3, Hina Arif-Tiwari4, Sumeet K Asrani5, Victoria Chernyak6, Alan Goldstein7, Joseph R Grajo8, Nicole M Hindman9, Aya Kamaya10, Michelle M McNamara11, Kristin K Porter11, Lilja Bjork Solnes12, Pavan K Srivastava13, Atif Zaheer14, Laura R Carucci15.   

Abstract

The liver fibrosis stage is the most important clinical determinate of morbidity and mortality in patients with chronic liver diseases. With newer therapies, liver fibrosis can be stabilized and possibly reversed, thus accurate diagnosis and staging of liver fibrosis are clinically important. Ultrasound, CT, and conventional MRI can be used to establish the diagnosis of advanced fibrosis/cirrhosis but have limited utility for assessing earlier stages of fibrosis. Elastography-based ultrasound and MRI techniques are more useful for assessment of precirrhotic hepatic fibrosis. In patients with advanced fibrosis at risk for hepatocellular carcinoma (HCC), ultrasound is the surveillance modality recommended by international guidelines in nearly all circumstances. However, in patients in whom ultrasound does not assess the liver well, including those with severe steatosis or obesity, multiphase CT or MRI may have a role in surveillance for HCC. Both multiphase CT and MRI can be used for continued surveillance in patients with a history of HCC, and contrast-enhanced ultrasound may have an emerging role in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2020 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; Cirrhosis; Elastography; Fibrosis; Hepatocellular carcinoma; Imaging; Liver disease

Mesh:

Year:  2020        PMID: 32370979     DOI: 10.1016/j.jacr.2020.01.023

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  2 in total

Review 1.  Magnetic resonance elastography: from invention to standard of care.

Authors:  Richard L Ehman
Journal:  Abdom Radiol (NY)       Date:  2022-07-19

2.  Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis.

Authors:  Marianna Alunni-Fabbroni; Sabine Weber; Osman Öcal; Max Seidensticker; Julia Mayerle; Peter Malfertheiner; Jens Ricke
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.